Parasitic infectious disease
MONDO:0005135A successful invasion of a host by an organism that uses the host for food and shelter.
Also known as: disease caused by parasite, parasitic disease, parasitic infection, ectoparasitic disease, parasitemia, disease, parasitic, diseases, parasitic, infestation
343 clinical trials for this condition and its sub-types, 12 tagged with Parasitic infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Parasitic infectious disease
-
Protozoa infectious disease 3 trials · 242 incl. sub-types
15 sub-types
- Malaria 135 trials · 170 incl. sub-types Sub-types →
- Leishmaniasis 8 trials · 27 incl. sub-types Sub-types →
- Trypanosomiasis 3 trials · 15 incl. sub-types Sub-types →
- Coccidiosis 0 trials · 13 incl. sub-types Sub-types →
- Trichomoniasis 10 trials · 12 incl. sub-types Sub-types →
- Acanthamoeba keratitis 5 trials
- Babesiosis 4 trials
- Giardiasis 2 trials
- Amebiasis 0 trials · 1 incl. sub-types Sub-types →
- Protozoal dysentery 0 trials · 1 incl. sub-types Sub-types →
- Balantidiasis 0 trials
- Dientamoebiasis 0 trials
- Granulomatous amebic encephalitis 0 trials
- Primary amebic meningoencephalitis 0 trials
- Theileriasis 0 trials
-
Helminthiasis 13 trials · 67 incl. sub-types
22 sub-types
- Nematoda infectious disease 0 trials · 27 incl. sub-types Sub-types →
- Schistosomiasis 15 trials · 17 incl. sub-types Sub-types →
- Cestode infectious disease 1 trial · 15 incl. sub-types Sub-types →
- Filariasis 10 trials · 15 incl. sub-types Sub-types →
- Intestinal helminthiasis 3 trials · 9 incl. sub-types Sub-types →
- Fascioliasis 2 trials
- Opisthorchiasis 2 trials
- Clonorchiasis 1 trial
- Necatoriasis 1 trial
- Acanthocephaliasis 0 trials
- Angiostrongyliasis 0 trials
- Dicrocoeliasis 0 trials
- Echinostomiasis 0 trials Sub-types →
- Fascioloidiasis 0 trials
- Fasciolopsiasis 0 trials
- Gnathomiasis 0 trials
- Heterophyiasis 0 trials
- Hymenolepiasis 0 trials
- Metagonimiasis 0 trials
- Monieziasis 0 trials
- Paragonimiasis 0 trials
- Trichostrongyloidiasis 0 trials Sub-types →
-
Parasitic skin disorder 1 trial · 37 incl. sub-types
6 sub-types
- Parasitic ectoparasitic infectious disease 0 trials · 16 incl. sub-types Sub-types →
- Cutaneous leishmaniasis 14 trials Sub-types →
- Demodex folliculitis 5 trials
- Infection by Trypanosoma gambiense 3 trials
- Cercarial dermatitis 0 trials
- Demodicidosis of sebaceous gland 0 trials
-
Parasitic eye infection 0 trials · 16 incl. sub-types
5 sub-types
- Parasitic eyelid infestation 0 trials · 9 incl. sub-types Sub-types →
- Parasitic endophthalmitis 0 trials · 5 incl. sub-types Sub-types →
- Ocular onchocerciasis 2 trials
- Ocular toxoplasmosis 1 trial
- Diffuse unilateral subacute neuroretinitis 0 trials
-
Parasitic intestinal disorder 0 trials · 16 incl. sub-types
7 sub-types
- Intestinal helminthiasis 3 trials · 9 incl. sub-types Sub-types →
- Cryptosporidiosis 5 trials
- Giardiasis 2 trials
- Protozoal dysentery 0 trials · 1 incl. sub-types Sub-types →
- Blastocystis infectious disease 0 trials
- Balantidiasis 0 trials
- Dientamoebiasis 0 trials
-
Cryptococcosis 5 trials · 10 incl. sub-types
1 sub-type
- Cryptococcal meningitis 7 trials
-
Demodicidosis 5 trials · 6 incl. sub-types
2 sub-types
- Demodex folliculitis 5 trials
- Demodicidosis of sebaceous gland 0 trials
-
Parasitemia 5 trials
-
Coccidioidomycosis 4 trials
-
Strongylida infectious disease 0 trials
-
Cutaneous larva migrans 0 trials
1 sub-type
- Larva migrans, visceral 0 trials
-
Distomatosis 0 trials
-
Microsporidiosis 0 trials
1 sub-type
- Encephalitozoonosis 0 trials
-
1 sub-type
- Rhinosporidiosis 0 trials
-
Parasitic myositis 0 trials
1 sub-type
- Trichinellosis 0 trials Sub-types →
Most studied deeper sub-types
-
Can a new vaccine stop malaria in its tracks?
Vaccine Stopped earlyThis early-stage trial is testing a new malaria vaccine candidate, called Pfs48/45, in healthy adults aged 18 to 45 in the UK. The vaccine is designed to block the malaria parasite from spreading, and it's given with an adjuvant called Matrix-M to boost the immune response. The s…
Early phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
Early malaria vaccine trial halted – what we know
Vaccine Stopped earlyThis early-stage trial tested a new vaccine against Plasmodium vivax malaria, given with an adjuvant to boost immune response. It involved 25 healthy adults in the UK to check safety and immune reactions. The study was terminated early, so full results are not available.
Early phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 08:12 UTC
-
New malaria pill for tiny infants studied, but trial stopped early
Disease control Stopped earlyThis study tested a new, easy-to-dissolve malaria tablet in infants and newborns weighing less than 5 kg who had uncomplicated malaria. The goal was to see how the medicine worked in the body, how safe it was, and how well it treated the infection. The trial was stopped early aft…
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Worm-Fighting combo pill tested in kids, but trial stopped early
Disease control Stopped earlyThis study tested a new pill combining two drugs (albendazole and ivermectin) to treat several types of intestinal worms in children and young adults aged 5 to 18. The goal was to see if the combination worked better than the standard single drug. However, the trial was terminate…
Phase 2/3 • Sponsor: Barcelona Institute for Global Health • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Leishmaniasis drug candidate tested in humans for first time – study halted early
Knowledge-focused Stopped earlyThis was a first-in-human study to check the safety and how the body processes a single dose of GSK3494245, a potential treatment for leishmaniasis. It involved 59 healthy adults who received up to three increasing doses of the drug or a placebo. The study was terminated early, s…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC